Cholangiocarcinoma immunotherapy at the 2018 CCF Annual Conference
Shared Information improves and Galvanises our Outcomes
What do you think about this video ? can you recommend a video? We welcome your comments?
Hear from Kate Kelley MD at the 2018 Cholangiocarcinoma Foundation Conference
Claire and Steve Holmes have poured everything into building a foundation that champions, initiates, and funds science, research, and best practices—dedicated to ensuring it reaches and benefits patients today and every day.
Their commitment has never wavered, but they cannot do this alone. Now, your support is critical—an essential catalyst to propel their vision even further. Please join us in this transformative mission.
“Alone we can do so little; together we can do so much.”
— Helen Keller. A symbol of extraordinary resilience and achievement over seemingly impossible obstacles.
$30 provides current information to patients and caregivers
$50 provides a navigator journal to a patient or caregiver
$100 supports our online meetings connecting and sharing patients journey
$250 provides one on one peer-to-peer telephone and video support
$500 assists with mentor programs for patients and caregivers
$1000 assists with patient endorsed medical registries
$5000 supports research and advancements to benefit today’s patient survival
Cholangiocarcinoma Foundation Australia is registered as a charity with the Australian Charities and Not-for-Profits Commission (ACNC). Cholangiocarcinoma Foundation Australia has Deductible Gift Recipient (DGR) status with the Australian Tax Office. Donations over $2 or more are tax-deductible. ABN: 93 665 038 102
The empowered patient is the future.
They transcend care — they drive response.
They integrate science, strategy, and resilience to outpace cancer in real time.
They don’t just follow the science — they lead it, inspire it, and clear the path for its application.
They don’t wait for breakthroughs — they force them forward.
They walk the talk of the most brilliant scientists alive today.
— Steve Holmes, Patient Survivor & Founder
